MetricSide LogoMetricSide
Learn
  1. Home
  2. Companies
  3. Healthcare
  4. ANAB
OverviewMetricsPricesRevenue & ProfitAssets & LiabilitiesCash FlowMarginsPrice RatiosOthers
MetricSide

Standardized stock fundamentals and valuation metrics. Analyze revenue, EBITDA, free cash flow, and more with interactive charts.

Stock Sectors

  • Technology
  • Healthcare
  • Financials
  • Consumer
  • Industrials
  • Energy
  • Real Estate
  • Materials

Legal & Contact

  • Terms of Service
  • Privacy Policy
  • Contact Us
Not Financial Advice: MetricSide is a data aggregation and visualization tool. Nothing on this website constitutes investment advice, a recommendation, or a solicitation to buy or sell any security. All data is provided for informational and educational purposes only. Past performance is not indicative of future results. Always consult a qualified financial professional before making investment decisions. Data accuracy is not guaranteed — verify critical information against official sources.

© 2026 MetricSide. All rights reserved.

AnaptysBio (ANAB) Financial Metrics 2020-2026

Key metrics and charts across all fundamental categories.

Prices

Stock price and market valuation

Stock Price
$55.06
344.3%
Market Cap
$1.58B
316.0%

ANAB trades at $55.06, a 344.3% increase year-over-year. Market capitalization stands at $1.58B, up 316.0% from the prior year. Track ANAB price trends and market cap history to understand how the market values this company over time.

Stock Price
How the market values the company over time
Market Cap
Total equity value as determined by the market

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares across quarters

TTM Revenue
$232.39M
107.7%
Q. Revenue
$25.56M
TTM EBITDA
$41.34M
141.5%
TTM Op. Income
$40.80M
140.7%
Q. Op. Income
$-34.64M
TTM Net Income
$-26.79M
81.0%
Q. Net Income
$-52.88M
EPS
$-1.84
Shares Out.
$28.69M
6.4%
$232.39M in TTM revenue grew 107.7% YoY, reaching $25.56M last quarter. TTM EBITDA of $41.34M and TTM operating income of $40.80M show growth is flowing through to the bottom line. However, net income is negative at $26.79M — growth is not yet reaching the bottom line.
TTM Revenue
Reveals whether the core business is growing or shrinking
Quarterly Revenue
Highlights seasonal patterns and short-term momentum
TTM EBITDA
Shows if underlying operating profitability is improving
Quarterly EBITDA
Tracks near-term operating profitability trends
TTM Operating Income
Smoothed operating profit over the past four quarters
Quarterly Operating Income
Profit from core operations before financing costs
TTM Net Income
The bottom line — is the company making more money?
Quarterly Net Income
Short-term profit after all expenses and taxes
EPS
Earnings per share — profit attributable to each share
Shares Outstanding
Declining means buybacks benefit remaining holders

Assets & Liabilities

Assets, cash, debt, book value, and leverage

Total Assets
$329.68M
Cash
$248.47M
Long-Term Debt
N/A
Book Value
$12.75M
D/E Ratio
N/A
Debt/EBITDA
N/A
Total Assets
Expanding asset base can indicate business growth
Cash & Equivalents
Shows liquidity available for opportunities or downturns
Long-Term Debt
Declining debt trend is generally positive
Book Value (Equity)
Growing book value signals intrinsic value creation
Debt / Equity
Lower means less reliance on borrowed money
Debt / EBITDA
Below 2x is conservative; above 4x is high

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow
$-25.92M
TTM Free Cash Flow
$4.41M
104.0%
FCF Margin
1.9%
FCF / Net Income
-0.2
TTM FCF of $4.41M on $-25.92M in operating cash flow. The FCF / Net Income ratio of -0.2x means the business consumes cash — it is not yet self-funding.
Operating Cash Flow
Cash generated from core business operations
Free Cash Flow
Cash the business generates after maintaining itself
FCF Margin (TTM %)
TTM FCF / TTM Revenue — 10%+ signals a capital-efficient business model
FCF / Net Income (TTM)
TTM FCF / TTM Net Income — above 1 means earnings are backed by real cash

Margins

Profit margins across the income statement

EBITDA Margin
-135.0%
Op. Margin
-135.5%
36.7%
Net Margin
-206.9%
46.1%
Op. margin of -135.5% is down 36.4% YoY — costs are rising relative to revenue. Net margin at -206.9%
Gross Margin (%)
Revenue left after direct cost of goods sold
EBITDA Margin (%)
Operating profitability independent of capital structure
Operating & Net Margins (%)
How much of each dollar becomes profit

Price Ratios

Valuation multiples — is the company cheap or expensive?

P/E Ratio
N/A
P/S Ratio
6.8x
P/B Ratio
123.9x
P/S of 6.8x and P/B of 123.9x.
P/E Ratio
Higher suggests growth expectations; lower may signal undervaluation
P/S Ratio
Useful when earnings are volatile or negative
P/B Ratio
Below 1 means trading below accounting book value
EV / EBITDA
Lower multiple often signals better value
FCF Yield (TTM %)
TTM FCF / Market Cap — compare to bond yields
Earnings Yield (%)
Earnings return at current price — inverse of P/E

Others

Return ratios, efficiency, and credit metrics

ROE
-210.1%
ROA
-8.1%
Asset Turnover
0.7
Rev/Share
$8.10
ROA of -8.1% shows how efficiently management uses assets to generate profit. Revenue per share at $8.1 removes dilution effects from top-line growth.
Return on Equity (ROE)
15%+ consistently signals a durable competitive advantage
Return on Assets (ROA)
How well management uses assets to generate profit
Asset Turnover
How efficiently assets generate each dollar of sales
Revenue per Share
Per-share revenue growth adjusted for dilution
Interest Coverage
How comfortably the company covers interest payments